How Jellyvision Hit $60M ARR in Employee Benefits — Under CEO Amanda Lannert, Not "Amanda Leonard"

Jellyvision passed $60 million in annual recurring revenue selling ALEX, its benefits decision-support platform, to large U.S. employers. CEO Amanda Lannert gave that number to Latka on November 7, 2018: ARR "north of 60 million," GAAP revenue north of $50 million, 1,400 employer customers covering 18 million employees — built on just $6.6 million of primary capital.

How Jellyvision reached $60M ARR

The model is a straight annual recurring license: employers pay per eligible employee for ALEX, which walks their people through health-insurance and benefits choices. Lannert described a sliding scale on the tape — up to $18 per employee per year at the smallest companies, down to roughly a quarter per employee per month at the largest. Deals run five, six, or seven figures, and she confirmed a six-figure average price point on new business.

The customers are deliberately huge. "Our business thrives on complexity," she said: the sweet spot is companies with 10,000-plus employees, and Jellyvision does particularly well with "jumbo" employers of 50,000 or more. Mid-market to Jellyvision means 2,000 to 10,000 employees. Her pitch for why the niche is big enough: "Ford spends more money per car on health insurance than it does steel, and one in four of their employees would rather clean a toilet than think about their benefits." Everything is U.S.-only, because employer-paid health insurance is, in her words, "a very uniquely American phenomenon."

One reconciliation worth making explicit: host Nathan Latka worked out on air that $60M across 1,400 customers is roughly $43,000 in average ACV, and Lannert accepted the math while noting she views the business annually. That $42.9K average now sits on the GetLatka profile. It coexists with her six-figure claim because the six figures describe new jumbo deals, while $43K is the blended average across a 1,400-customer book that includes much smaller accounts.

From "You Don't Know Jack" to ALEX

Every date below comes from Lannert's own telling on the November 2018 tape.

Jellyvision started in the 1990s as a gaming company, famous for CD-ROM titles like "You Don't Know Jack" and the "Who Wants to Be a Millionaire" game. The hits business proved too fickle — "we had figured we had used up all of our luck" — so in 2002 the company relaunched as a B2B business with a small $1.6 million round, betting that its virtual-game-show-host technology could power virtual advisors for decisions that are "complicated and boring but important."

Product-market fit took most of a decade. From 2002 to roughly 2010 Jellyvision operated more or less as a digital agency, doing bespoke projects for large companies. ALEX "isn't the first time we tried to productize and scale what we do — it's just the first time it worked." Momentum arrived in 2011–2012 as the company started selling ALEX directly, and by 2016 it had become the sole focus. As Lannert put it, "it certainly was a longer-tailed start" than most SaaS stories.

The unit economics behind the $60M

The earlier version of this post rendered the ratio as "CAC to LTV of 11:1," which would mean spending eleven dollars to acquire one dollar of lifetime value. Lannert's actual point was the opposite — lifetime value runs about eleven times acquisition cost — which is consistent with the 8.8-month payback she cited in the same breath.

The gap between the $50M and $60M figures is bookings seasonality, not fuzziness. Jellyvision's "tax day happens in November": licenses start around open enrollment, revenue is recognized pro rata from there, so recognized revenue trails bookings. Two more claims from the tape round out the picture: cash-flow positive since 2009, and profitable in 2018 with, as she said then, "line of sight to substantially improved margins by 2020."

Growth inside the existing book did real work. Gross churn of up to 10% a year was more than recouped by expansion — the most successful cross-sell being a leave-of-absence navigation product answering, in Lannert's framing, the two questions every employee on leave has: "Am I going to get fired, and am I going to get paid?" She called it "a mini business unit in and of itself." One small strategic acquisition, unnamed on the tape, bolted on pricing-optimization technology; everything else was organic.

Funding: $27M raised, but only $6.6M ever hit the balance sheet

The old version of this article claimed Jellyvision "raised $27 million in 2022, primarily through a secondary round." No such 2022 round exists in any record we can find. Here is what Lannert actually said in November 2018: $27 million raised in total, of which only $6.6 million was primary capital — $1.6 million at the 2002 relaunch and $5 million in 2007. The remaining $20 million was a secondary round that closed in 2017, in which early employees (cut off by hire date, not seniority) and early investors sold shares; Series B backer Sigma Partners chose to keep its chips on the table. "We haven't put cash on the balance sheet in over a decade," she said.

Two wrinkles, flagged openly. GetLatka's Jellyvision profile records $25M across two rounds — a $5M Series B in 2008 and the $20M round in 2017 — omitting the 2002 seed money and dating the Series B a year later than Lannert did on the tape. And the profile logs the $20M as a venture round, while on the tape it is explicitly a secondary. On both points we treat the CEO's first-person account as primary.

What happened after the tape

The $60M figure is now nearly eight years old, and it remains the last revenue number Jellyvision has confirmed to GetLatka — the old post's claim of a "50% CAGR maintained through 2023" had no source, and we will not repeat it. What Lannert actually claimed was a five-year CAGR north of 50% as of November 2018.

The public record since then, for what it shows:

• Headcount tracked by GetLatka rose from 392 in December 2018 to 458 in December 2019 — close to the "about 470" plan Lannert gave on the tape — then drifted down to roughly 315 by late 2023, where it has held through 2024. The company is smaller today than at its 2019 peak.
• In January 2023 Jellyvision acquired Picwell, a healthcare-analytics startup backed by Aflac Ventures and BlueCross BlueShield Venture Partners, to add predictive benefits recommendations to ALEX (announced via GlobeNewswire, January 9, 2023). Terms were not disclosed. It fits the pattern she described in 2018: small strategic buys to bolt on algorithms, growth otherwise organic.
• Amanda Lannert remains CEO — she was profiled in that role by Entrepreneur in October 2024, and Jellyvision's own materials say ALEX now serves a quarter of the Fortune 500.

Jellyvision remains private and has published no post-2018 revenue figures, so whether ARR grew from $60M is genuinely unknown. Shorter and true: as of the last verified data point, this was a roughly $60M ARR, cash-flow-positive Chicago company that got there on $6.6 million of primary capital — a story that needs no invented timeline to be worth telling.